RG 7345

Drug Profile

RG 7345

Alternative Names: RG7345; RO-6926496

Latest Information Update: 31 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antidementias; Monoclonal antibodies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Alzheimer's disease

Most Recent Events

  • 01 Jan 2015 Phase-I clinical trials in Alzheimer's disease (In volunteers) in United Kingdom (IV) (NCT02281786)
  • 30 Oct 2014 Preclinical trials in Undefined indication in Switzerland (IV)
  • 30 Oct 2014 Roche plans a phase I trial for Healthy volunteers in the UK (NCT02281786)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top